{"id":48864,"date":"2022-09-27T16:02:23","date_gmt":"2022-09-27T14:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/"},"modified":"2022-09-27T16:02:23","modified_gmt":"2022-09-27T14:02:23","slug":"guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/","title":{"rendered":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer"},"content":{"rendered":"
\n

BIRMINGHAM, Ala.–(BUSINESS WIRE)–Guideway Care<\/a>, an innovative healthcare company dedicated to advancing health equity, optimizing patient outcomes and lowering total costs in Value-Based Care, takes pleasure in announcing that its Chief Medical Officer, Dr. Edward Partridge, was selected as the Honoree for 2022 Beyond Blue Benefit to End Prostate Cancer sponsored by the Mike Slive Foundation<\/a>, the first and only dedicated prostate cancer nonprofit organization in the Southeast. A ceremony was hosted by ESPN\u2019s Laura Rutledge on Thursday, September 22, 2022, at Protective Life Stadium Club, Birmingham, AL.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Partridge is the driving force behind Guideway\u2019s mission to deliver solutions and services that resolve patient barriers to accessing quality care within oncology practices, health systems, risk-bearing entities, payers, bundle participants and behavioral health client partners\u2019 populations. Having developed over 70 non-clinical and clinical assessments, covering social determinants of health and most disease states, the Guideway Service as a Solution drives health equity and financial performance by resolving patient barriers related to health-related social needs, practical concerns and other impediments to compliance with clinical instructions.\n<\/p>\n

\n\u201cI am truly blessed and honored to receive this distinctive tribute from an esteemed organization like the Mike Slive Foundation,\u201d says Dr. Partridge. \u201cMike Slive was a friend of mine, and his foundation is leading the way in raising awareness and funding research which can end prostate cancer as a major public health threat in our lifetime. I\u2019ve spent my life dedicated to increasing awareness of cancer and access to screening and treatment. Now more than ever, it is imperative to make a difference in the lives of so many individuals who struggle to access care and avoid hospitalizations during these challenging times.\u201d\n<\/p>\n

\nIn addition to his role as CMO of Guideway, Dr. Partridge is Director Emeritus and Professor Emeritus of the UAB Comprehensive Cancer Center. Throughout his long career in medicine, Dr. Partridge has translated academic research into practical real-world applications, particularly in the areas of cancer prevention and the reduction of disparities in health care. Dr. Partridge served as President of the National Board of the American Cancer Society as well as Chairman of the Commission on Cancer for the American College of Surgeons. He is also on the Board of Directors of the Mid-South Division of the American Cancer Society.\n<\/p>\n

\nProstate cancer<\/a> is the most common non-skin cancer affecting one in eight men in their lifetime. When detected early, many prostate cancers can be treated successfully.\n<\/p>\n

\nCraig Parker, CEO, Guideway Care says, \u201cWe are incredibly proud of Dr. Partridge and the impact he has made through a lifetime of commitment to cancer patients and their treatment. This award from the Mike Slive Foundation is another testament to the difference he has made.\u201d\n<\/p>\n

\nAbout Guideway Care
\n
<\/b>For more than 10 years Guideway Care has delivered a proven, scalable technology-enabled Service as a Solution for advancing health equity in Value-Based Care. Partnering with hospitals, health systems, payers and provider organizations, Guideway reduces health disparities, improves patient\/member satisfaction and lowers total cost of care. Highly trained Care Guides, supported by a proprietary technology platform, build peer-to-patient relationships that allow for the identification and resolution of non-clinical and clinical barriers to accessing quality care. By maximizing the patient care experience and resolving barriers that lead to avoidable deterioration and acute care utilization, the Guideway Care approach to patient activation creates value for all stakeholders. www.guidewaycare.com<\/a>\n<\/p>\n

\nAbout the Mike Slive Foundation
\n
<\/b>The Mike Slive Foundation for Prostate Cancer Research endeavors to become a global leader in the fight to eradicate prostate cancer through public awareness and research funding in memory of Mike Slive, a transformative leader whose vision and direction revolutionized the business of collegiate sports. Founded in Birmingham, Alabama, by attorney Ed Meyerson and former SEC and Conference USA Commissioner Mike Slive, the foundation comprises local business, medical and political leaders. https:\/\/mikeslivefoundation.org\/beyond-blue\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Michael Berger
\n
CPR for Guideway Care
\n
mberger@cpronline.com<\/a>
201.641.1911 x 60\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BIRMINGHAM, Ala.–(BUSINESS WIRE)–Guideway Care, an innovative healthcare company dedicated to advancing health equity, optimizing patient outcomes and lowering total costs in Value-Based Care, takes pleasure in announcing that its Chief Medical Officer, Dr. Edward Partridge, was selected as the Honoree for 2022 Beyond Blue Benefit to End Prostate Cancer sponsored by the Mike Slive Foundation, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48864","6":"format-standard","7":"category-industry"},"yoast_head":"\nGuideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BIRMINGHAM, Ala.–(BUSINESS WIRE)–Guideway Care, an innovative healthcare company dedicated to advancing health equity, optimizing patient outcomes and lowering total costs in Value-Based Care, takes pleasure in announcing that its Chief Medical Officer, Dr. Edward Partridge, was selected as the Honoree for 2022 Beyond Blue Benefit to End Prostate Cancer sponsored by the Mike Slive Foundation, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-27T14:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer\",\"datePublished\":\"2022-09-27T14:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005161\\\/en\\\/1582770\\\/21\\\/Edward_Partridge_MD.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/\",\"name\":\"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005161\\\/en\\\/1582770\\\/21\\\/Edward_Partridge_MD.jpg\",\"datePublished\":\"2022-09-27T14:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005161\\\/en\\\/1582770\\\/21\\\/Edward_Partridge_MD.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005161\\\/en\\\/1582770\\\/21\\\/Edward_Partridge_MD.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend","og_description":"BIRMINGHAM, Ala.–(BUSINESS WIRE)–Guideway Care, an innovative healthcare company dedicated to advancing health equity, optimizing patient outcomes and lowering total costs in Value-Based Care, takes pleasure in announcing that its Chief Medical Officer, Dr. Edward Partridge, was selected as the Honoree for 2022 Beyond Blue Benefit to End Prostate Cancer sponsored by the Mike Slive Foundation, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-27T14:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer","datePublished":"2022-09-27T14:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/"},"wordCount":671,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/","url":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/","name":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg","datePublished":"2022-09-27T14:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220927005161\/en\/1582770\/21\/Edward_Partridge_MD.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Guideway Care Chief Medical Officer Edward E. Partridge, MD Honored at 2022 Beyond Blue Benefit to End Prostate Cancer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48864"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48864\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}